Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
Year: 2017
Type: article
Study design: Observational Study
Abstract: Brain autopsy and biomarker studies indicate that the pathology of Alzheimer’s disease (AD) is initiated at least 10–20 years before clinical symptoms. This provides a window of opportunity to initiate preventive treatment. However, this emphasizes the necessity for biomarkers that identify individuals at risk for developing AD later in life. In this cross-sectional study, originating from three epidemiologic studies in Sweden ( n =1428), the objective was to examine whether amyloid pathology, as determined by low cerebrospinal fluid (CSF) concentration of the 42 amino acid form of β-amyloid (Aβ42), is associated with biomarker evidence of other pathological changes in cognitively healthy elderly. A total of 129 patients were included and CSF levels of Aβ42, total tau, tau phosphorylated at threonine 181 (p-tau), neurogranin, VILIP-1, VEGF, FABP3, Aβ40, neurofilament light, MBP, orexin A, BDNF and YKL-40 were measured. Among these healthy elderly, 35.6% ( N =46) had CSF Aβ42 levels below 530 pg ml −1 . These individuals displayed significantly higher CSF concentrations of t-tau ( P <0.001), p-tau (181) ( P <0.001), neurogranin ( P =0.009) and FABP3 ( P =0.044) compared with amyloid-negative individuals. Our study indicates that there is a subpopulation among healthy older individuals who have amyloid pathology along with signs of ongoing neuronal and synaptic degeneration, as well as tangle pathology. Previous studies have demonstrated that increase in CSF tau and p-tau is a specific sign of AD progression that occurs downstream of the deposition of Aβ. On the basis of this, our data suggest that these subjects are at risk for developing AD. We also confirm the association between APOE ɛ4 and amyloid pathology in healthy older individuals.
Source: Translational Psychiatry
DOI: 10.1038/tp.2016.252
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, amyloid pathology, cerebrospinal fluid biomarkers, amyloid-beta 42, total tau, neurogranin, FABP3, neurodegeneration, healthy older adults, APOE ε4, preclinical Alzheimer's disease, neurofibrillary tangles, neurofilament light chain, vascular endothelial growth factor, VILIP-1, orexin-A, brain-derived neurotrophic factor, YKL-40, MBP
Open Access status: gold
Estimated APC paid: $5,290
Awards: G1245322297, G1681703157, G1776849529, Dementia among 85-year-olds examined in 1986-87 and 2009, G3617411373, G3723744389, G4030908861, G4045653179, G5168374444, G5245164231, G610756488, Searching for new physics at the Large Hadron Collider in the Higgs era, G665917651, G7135147072, G76492528, G8671169300, G8880098891, G8956745629
OpenAlex ID: W2571225994
